BloodSTOP® and BloodSTOP® iX are biocompatible, non-irritating, woven matrices of fibers made from natural plant compounds. They adhere to a wound, initiate blood coagulation, stop bleeding, and form a protective layer to create an optimal environment for wound healing. Their water solubility allows for removal by rinsing, without disruption of a clotted surface.

 

These products are covered by U.S. Patent No. 7,262,181.

 

News Releases

12/07/13

LSP has exclusive patent rights

   LifeSciencePLUS PRESS RELEASE

December 5, 2013

LifeScience PLUS announced today that it has acquired exclusive patent rights to US and corresponding foreign patents covering water-soluble, oxidized - etherified regenerated cellulose materials.  CEO and President of LifeScience PLUS, Vicky Feng, said today that while her company has for several years sold its Hemostatic BloodSTOP and BloodSTOP iX wound care products under license from the original owners of US Patent 7,262,181 which was granted in 2007, the company has been successful in negotiating an exclusive license with full rights to sub-license and otherwise enforce the patents worldwide.  She further indicated that  her company is considering the implementation of an industry-wide licensing program intended to insure that all covered products sold by the company's licensees are manufactured and marketed in accordance with the highest possible safety standards.  

12/06/12

BloodSTOP now approved in EU for use with blood thinning medications!

LifeSciencePLUS, Inc., is pleased to announce the recertification of its Class IIb CE Mark Certification for the BloodSTOP® line of topical hemostats.  The recertification has been extended to include bleeding control for people on anti-coagulant medications.

09/28/12

Efficacy Studies of BloodSTOP® iX as compared with Surgicel® and Gelfoam®

UCSF preclinical study done in conjunction with University Hospital Pellegrin in France shows BloodSTOP iX® controls bleeding up to three times faster than Gelfoam® or Surgicel®.

05/01/12

BloodSTOP® and BloodSTOP® iX Effective at Controlling Bleeding on Test Subjects Receiving Coumadin, Aspirin & Plavix, and Heparin

A preclinical study performed in accordance with GLP guidelines, tested BloodSTOP and BloodSTOP iX on a group of animals receiving anticoagulant drugs against a control subject that received none.  Tests showed hemostasis was achieved in the anticoagulant group in a time that was statistically significant and comparable to that of the control subject.

04/10/12

Walgreens and Curad brands now offer our hemostat technology

LifeScience PLUS, Inc., announces today that it has partnered with Medline Industries for the launch of Curad® BloodSTOP and  Walgreens® Blood Barrier Hemostat Gauze with its BloodSTOP technology.

03/08/12

BloodSTOP on ABC7 News, KGO-TV, San Francisco!

Watch the news story which covered BloodSTOP products from ABC7 News, KGO-TV, San Francisco.

03/01/11

BloodSTOP® Technology Picked up by CVS Drug Stores

LifeScience PLUS, Inc., announces today that it has signed a store brand agreement for the supply of its proprietary hemostat technology to CVS.

04/17/10

LifeScience PLUS Sends BloodSTOP® Products to Haiti

LifeScience PLUS has donated $43,000 worth of BloodSTOP products to the Haiti earthquake relief effort through theCatholic Medical Mission Board for the medical treatment of wounds sustained in the recent crisis. 

11/25/09

KERR DRUG Offers Customers the Exciting New Hemostat, BloodSTOP

Kerr Drug has brought a new bleeding control solution to their market with the introduction of BloodSTOP®Hemostatic Gauze, manufactured by LifeScience PLUS.  

10/27/09

BloodSTOP on Fox News

Watch a video of BloodSTOP being featured on Fox News.

10/27/09

BloodSTOP on CBS News

Watch the video of BloodSTOP on CBS News.

01/22/09

LifeSciencePLUS Obtains the CE Mark for BloodSTOP® iX Absorbable Hemostat

 LifeSciencePLUS, Inc., is pleased to announce that BloodSTOP® iX Absorbable Hemostat has been granted the Class III CE Mark certification for internal wounds.  Already in medical markets overseas as a surface wound hemostat, BloodSTOP® iX will now be offered to the internal, surgical market in Europe.

10/15/08

LifeScience PLUS Introduces BloodSTOP

LifeScience PLUS today announced the introduction of its proven fast-acting BloodSTOP hemostatic products in global markets. The company's patent pending hemostatic technology brings a new level of efficacy to the wound care market.

11/01/07

LifeSciencePLUS Obtains CE Mark Certification for the BloodSTOP® Product Line

LifeSciencePLUS, Inc., is pleased to announce that BloodSTOP® has been granted the Class IIb CE Mark certification for the control of bleeding from all surface wounds.  “We are pleased to be able to extend our markets for this breakthrough product beyond the US and into the European markets,” said Vicky Feng, President and CEO.

09/01/07

FDA Clearance of BloodSTOP® Leads to New Retail Wound Management Category

 BloodSTOP®, a 100% natural fiber cellulose gauze which quickly stops bleeding, has now been cleared by FDA for marketing to consumers. BloodSTOP®, initially used by Medical Professionals to effectively manage blood loss and speed up healing, has now been designed for the consumer and is available at drug stores.

02/01/06

BloodSTOP reviewed in "Dental Economics"

Dr. Joe Blaes, DDS, reports on BloodSTOP®.

02/01/06

BloodSTOP featured in "Dentistry Today"

Dr. George Fredman, DDS, gives his impressions of BloodSTOP® based on his clinical experience.